Domov › Melanom › Utah › Salt Lake City
Klinične študije za Melanom v Salt Lake City, UT
21 študij za Melanom išče udeležence na lokacijah v Salt Lake City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute, Salt Lake City
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Vključevanje udeležencevFaza 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Vključevanje udeležencevFaza 3
- Intermountain Health, Salt Lake City
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Vključevanje udeležencevFaza 2
- Primary Children's Hospital, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Vključevanje udeležencevFaza 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Vključevanje udeležencevOpazovalna študija
- Utah Cancer Specialists, Salt Lake City
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Project: Every Child for Younger Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Primary Children's Hospital, Salt Lake City
Rural Adult and Youth Sun Protection Study
Vključevanje udeležencevVabljeni zdravi prostovoljci
- University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Vključevanje udeležencev
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Vključevanje udeležencev
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Vključevanje udeležencevFaza 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Vključevanje udeležencevFaza 3
- Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute - University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Vključevanje udeležencev
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Študije za Melanom v drugih mestih
- Houston, TX59 študij
- New York City, NY38 študij
- Los Angeles, CA34 študij
- Nashville, TN33 študij
- Pittsburgh, PA31 študij
- Boston, MA26 študij
- Philadelphia, PA23 študij
- San Francisco, CA22 študij
- Columbus, OH21 študij
- Durham, NC21 študij
- Atlanta, GA21 študij
- St. Louis, MO21 študij
Druge študije v Salt Lake City
- Nemalicelični pljučni rak31 študij
- Rak (vse vrste)27 študij
- Rak dojke27 študij
- Kolorektalni rak22 študij
- Rak pljuč21 študij
- Množni mielom21 študij
- Metastatski rak20 študij
- Rak jajčnikov19 študij
- Debelost18 študij
- Akutna mieločna levkemija17 študij
- Srčno popuščanje17 študij
- Rak prostate15 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.